Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M39.3Revenue (TTM) $M0.9Net Margin (%)-2,728.8Altman Z-Score-14.1
Enterprise Value $M17.3EPS (TTM) $-2.4Operating Margin %-3,223.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.1Pre-tax Margin (%)-2,728.8Higher ROA y-yY
Price/Book6.110-y EBITDA Growth Rate %-29.9Quick Ratio5.4Cash flow > EarningsN
Price/Sales34.05-y EBITDA Growth Rate %-51.3Current Ratio5.4Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-63.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-217.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M13.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with AEZS

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

AEZS is held by these investors:



AEZS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ernst, JürgenDirector 2014-11-12Buy600$60-95.08view
Ernst, JürgenDirector 2014-11-12Buy394$61.79-95.23view
Ernst, JürgenDirector 2014-11-12Buy76$61.49-95.2view
Ernst, JürgenDirector 2014-11-12Buy31$61.4-95.2view
Ernst, JürgenDirector 2014-11-12Buy149$61.46-95.2view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy85$56.5-94.78view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy10$56.97-94.82view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy344$57-94.82view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy30$57.5-94.87view
Dodd, David AlanDirector, Senior Officer 2014-11-10Buy1,281$58-94.91view

Quarterly/Annual Reports about AEZS:

    News about AEZS:

    Articles On GuruFocus.com
    Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
    Can Keryx Succeed Without Partnership? Apr 24 2012 
    Keryx Still Has High Potential from Zerenex Apr 12 2012 
    Opportunistic Coat-tailing Jan 05 2010 

    More From Other Websites
    5:03 pm Aeterna Zentaris commences new 'at-the-market' offering of up to 3 mln common shares... Mar 28 2017
    Aeterna Zentaris Announces At the Market Issuance Program Mar 28 2017
    Æterna Zentaris, Inc. :AEZS-US: Earnings Analysis: Q4, 2016 By the Numbers : March 27, 2017 Mar 27 2017
    AETERNA ZENTARIS INC. Financials Mar 22 2017
    Aeterna Zentaris reports 4Q loss Mar 15 2017
    Aeterna Zentaris reports 4Q loss Mar 15 2017
    Aeterna Zentaris Reports Fourth Quarter and Full-Year 2016 Financial and Operating Results Mar 15 2017
    Aeterna Zentaris Announces EMA Pediatric Committee Agreement on the Pediatric Investigation Plan for... Mar 07 2017
    Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2016 Financial and Operating Results on... Mar 06 2017
    Aeterna Zentaris Announces Presentation Regarding Macrilen™ at 99th Annual Meeting of the... Mar 02 2017
    Tenet Healthcare (THC) to Divest Operations to Amedisys Mar 02 2017
    Aeterna Zentaris Announces Zoptrex™ Presentation in Prostate Cancer at 2017 Genitourinary Cancers... Feb 14 2017
    Aeterna Zentaris Announces Plans to Pursue FDA Registration of Macrilen™ Feb 13 2017
    Aeterna Zentaris to Present at the 2nd Annual Disruptive Growth & Healthcare Conference Feb 09 2017
    Aeterna Zentaris to Present at the 2017 BIO CEO and Investor Conference Feb 07 2017
    Drug Approvals Expected to Rise as Trump Pledges to Speed Up Approval Process: Latest Reports on... Feb 01 2017
    Expectations Run High At AEterna Zentaris Inc. (USA) (AEZS) As Two New Drugs Enter Final Testing... Jan 31 2017
    Aeterna Zentaris Announces Completion of Zoptrex™ Pivotal Phase 3 Clinical Trial in Advanced... Jan 30 2017
    Biotech Industry Outperforming Markets in 2017: Latest Reports on Pulmatrix and Aeterna Zentaris Jan 18 2017
    Dryships, Agile Therapeutics in Thursday’s 52-Week Low Club Jan 05 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)